ABSTRACT:
Simple sensitive and accurate ion pair complex formation with reactive dyes, extractive spectrophotometric methods have developed for the estimation of emtricitabine in pharmaceutical dosage form. The methods are based on the formation of ion paired coloured complexes by the drug with reactive dyes like Congo red, eriochrome black T and methyl orange in acidic medium. The ion associated complexes were formed and quantitatively extracted under the experimental condition in chloroform. The absorbance values were measured at 490nm, 500nm, and 430nm respectively. The proposed methods were validated statistically. Recoveries of methods were carried out by standard addition method. The linearity was found to be 5.0-30.0µg/ml, 2 -14 µg/ml, and 2-18µg/ml for methods respectively. The low values of standard deviation and percentage RSD indicate high precision of methods. Hence these methods are useful for routine estimation of emtricitabine in pharmaceutical dosages.
Cite this article:
Rele Rajan V., Tiwatane Prathamesh P.. Validation of Emtricitabine by Application of Reactive Dyes in from Pharmaceutical Dosages. Asian Journal of Research in Chemistry. 2025; 18(1):1-4. doi: 10.52711/0974-4150.2025.00001
Cite(Electronic):
Rele Rajan V., Tiwatane Prathamesh P.. Validation of Emtricitabine by Application of Reactive Dyes in from Pharmaceutical Dosages. Asian Journal of Research in Chemistry. 2025; 18(1):1-4. doi: 10.52711/0974-4150.2025.00001 Available on: https://ajrconline.org/AbstractView.aspx?PID=2025-18-1-1
REFERENCES:
1. Dinesh Dhatkar, Sufiyan Ahmad, V. M. Shastry, Development and Validation of UV-Visible Spectrophotometric Method for Estimation of Emtricitabine and Tenofovir in Bulk and Dosage Form. International Journal of Pharmacy and Pharmaceutical Research. 9 (3); 2017: 74-84
2. Budagam Lavanya et.al. Method development and validation of combined dosage form of Emtricitabine and Tenofovir disproxil fumarate by ultra violet spectroscopy. International Research Journal of Pharmacy. 2012; 3(12): 104-108.
3. Anindita Behera, Aurobinda Parida1, Amit Kumar Meher, Dannana Gowri Sankar, Swapan Kumar Moitra1, Sudam Chandra Si. Development and Validation of Spectrophotometric method for determination of Emtricitabine and Tenofovir disoproxil Fumarate in Bulk and Tablet dosage form. International Journal of Pharm Tech Research. 2011; 3(3): 1874-1882.
4. Mohammad H. AbdelHay, Azza A. Gazy, Rasha A. Shaalan, and Heba K. Ashour, Simple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in Tablets. Journal of Spectroscopy. 2013, Article ID 937409, 7 pages, http://dx.doi.org/10.1155/2013/937409.
5. Rajan V. Rele, Prathamesh P. Tiwatane. Derivative UV Spectrophotometric Method for Validation of Emtricitabine in Bulk and Pharmaceutical Dosage Form. Asian J. Research Chem. 2020; 13(1): 48-51. DOI: 10.5958/0974-4150.2020.00011.5
6. Rajan V. Rele UV Spectrophotometric Estimation of Emtricitabine by Zero order and area under Curve methods in Bulk and Pharmaceutical Dosage Form. Asian J. Research Chem. 2019; 12(5): 263-267. DOI: 10.5958/0974-4150.2019.00049. X.
7. Rajan V. Rele Sandip Patil. Development of Analytical Method by RP-HPLC Method for Validation of Emtricitabine in API and Pharmaceutical Dosage Form. Asian J. Research Chem. 2019; 12(3): 143-147. DOI: 10.5958/0974-4150.2019.00029.4
8. Bhushan P. Badgujar, Moreshwar P. Mahajan, Sanjay D. Sawant. development and validation of RP-HPLC method for the simultaneous estimation of tenofovir alafenamide and emtricitabine in bulk and tablet dosage form. International Journal of ChemTech Research. 2017; 10(5): 731-739.
9. Arun Ramaswamy A, Anton Smith Arul Gnana Dhas. Development and validation of analytical method for quantitation of emtricitabine, tenofovir, efavirenz based on HPLC. Arabian Journal of Chemistry. 2018; 11: 275–281.
10. Ajay D. Mali and Uttam B. More. RP-HPLC method for simultaneous estimation of impurities from emtricitabine and tenofovir disoproxil fumarate tablet. International Journal of Pharmaceutical Sciences and Research. 2016; 7(4): 1662-1669.
11. Mallikarjuna Rao Nagasarapu and Gowri Sankar Dannana. Development and validation of stability-indicating HPLC -DAD method for simultaneous determination of emtricitabine, elvetegravir, cobicistat and tenofovir in their tablet dosage forms. Indian Journal of Pharmaceutical Education and Research. 2016; 50(1): 205-211.
12. Kalpana Jayapalu, Himaja Malipeddi, Anbarasu Chinnasamy. Chromatographic separation and in vitro dissolution assessment of tenofovir disoproxil fumarate, emtricitabine and nevirapine in a fixed dose combination of antiretrovirals, Journal of Applied Pharmaceutical Science. 2014; 4(11): 76-80.
13. Varma D and A Lakshmana Rao. Stability-Indicating RP-HPLC method for the simultaneous estimation of efavirenz, tenofovir and emtricitabine in pharmaceutical formulations. Indian Journal of Pharmacy and Pharmacology. 2014; 1(1): 1-17.
14. Bala Rami Reddy.Yenumula1, Mutta Reddy. Singampalli and Bala Sekhara Reddy. Challa, Simultaneous estimation of emtricitabine and tenofovir disoproxil fumarate in tablet dosage form by reverse phase high-performance liquid chromatography. International Journal of Analytical Techniques. SOJ Chromatograph Sci. 2015; 1(1): 6.2-6.
15. Prashant S. Devrukhakar, Roshan Borkar, Nalini Shastri, and K. V. Surendranath. A Validated stability-indicating RP-HPLC method for the simultaneous determination of tenofovir, emtricitabine, and a efavirenz and statistical approach to determine the effect of variables. ISRN Chromatography. 2013, Article ID 878295, 8 pages, http://dx.doi.org/10.1155/2013/878295.
16. N.MD. Akram, M. Umamahesh N. A new validated RP-HPLC method for the determination of emtricitabine and tenofovir af in its bulk and pharmaceutical dosage forms. Journal of Chemical and Pharmaceutical Sciences. 2017; 10(4): 54-59.
17. Srinivasa Rao A, Naveen Kumar G, Srilekha K, Aruna Kumari N. Stability indicating method for the simultaneous estimation of tenofovir, emtricitabine and efavirenz in pure and pharmaceutical dosage form by RP-HPLC. 2016; 5(5):188-200.
18. Umesh Maniyar, M. V. Katariya, Kishor Kumar Koshe, Gopal Karva, Sushil Jaiswal. Stability indicating RP-HPLC method for the simultaneous estimation of efavirenz, emtricitabine and tenofovir disoproxil fumarate in combined pharmaceutical dosage form. World Journal of Pharmacy and Pharmaceutical Sciences. 2016; 5(6): 1180-1198.
19. SK Mastanamma, D Venkata Reddy, P Saidulu and M Varalakhimi. Development and validation of stability indicating RP-HPLC method for the simultaneous estimation of emtricitabine tenofovir alafenamide bulk and their combined dosage form. Journal of Chemical and Pharmaceutical Research. 2017; 9(9): 70-80.
20. Som Shankar Dubey and Mahesh Duggirala. High performance liquid chromatography with PDA detector for combined determination of emtricitabine, tenofovir and efavirenz. Der Pharmacia Lettre. 2015; 7(10): 85-91.
21. P.D. Hamarapurkar, Abhijeet N. Parate. HPLC method for the determination of emtricitabine and related degradation substances. Journal of Chromatographic Science. https://academic.oup.com/chromsci/article/51/5/419/326539.
22. Md Abdul Sattar and Suneetha Achanta. Analytical Method Development and validation for the determination of emtricitabine and tenofovir disoproxil fumarate using reverse phase hplc method in bulk and tablet dosage form. Journal of Pharmaceutical Science and Research. 2018; 10(5): 1207-1212.
23. J. Saminathan and T. Vetrichelvan. Development and validation of HPTLC method for simultaneous estimation of emtricitabine, rilpivirine and tenofovir disoproxil fumarate in combined dosage form. Bangladesh Pharmaceutical Journal. 2016; 19(1): 114-121.
24. Mahesh S. Wajurkar, Manjusha N. Dole. Development and validation of HPTLC method for determination of emtricitabine in API and tablet dosage form. Journal of Advanced Scientific Research. 2015; 6(3): 51-54.